HomeFUNDING
FUNDING
Medical device and diagnostics companies are always looking for ways to improve their products and services. In the ever-changing landscape of the healthcare industry, it’s essential for these companies to stay ahead of the curve. That’s why funding is always news.
Series A, B, and other rounds of funding are essential for medical device and diagnostics companies. They provide the necessary capital to help these businesses grow and innovate. And with so many investors interested in this space, there are plenty of opportunities for companies to secure the funding they need.
German Federal Ministry of Education and Research Awards Grants to Gund a Clinical Trial for LISA Laser Innovated “Novel Treatment of Urolithiasis”
Urolithiasis is a common disease affecting about 12% of the global population. Consequently, urolithiasis is a widespread disease with significant socioeconomic impact and is relevant to healthcare in terms of society and health policy.
American Injectables Announces Validation of its Tampa Operations
American Injectables is now well positioned to help fill the gap in US-based manufacturing of sterile injectables to alleviate current drug shortages.
Theranica Secures $45 Million Series C Funding Round
Theranica advises the proceeds will fund the U.S. commercial expansion of migraine treatment device , Nerivio®
Avenda Health Raises $10M in Series B
Avenda Health notes the capital will be used to accelerate the use of iQuest, an AI-enabled patient management software that identifies and visualizes a patient's prostate cancer. The funding will also be used to continue clinical evidence development.
Levee Medical Reports Closing of $6.6 Series A Financing
Levee Medical notes the funds will be used to advance product development, scale infrastructure, and expand the team to support the development of the company’s Voro Urologic Scaffold, a bioresorbable post-prostatectomy implant.
NeuroOne Announces $3.5 Million Accelerated Milestone Payment from Zimmer Biomet for Evo® sEEG Electrode
NeuroOne notes the amendment provides Zimmer Biomet with 350,000 warrants with exercise price of $3.00 per share.
Partnership for Economic Innovation Secures Funding for Wearable Technology Research
Partnership for Economic Innovation notes the applied research model accelerates product development and commercialization by combining private and public sector.
Successful Completion of Series A: EUR 10 Million Investment for Medtech Startup PreciPoint
PreciPoint will launch the iO:M8 ROSE solution to customers in 2022, a globally unique solution for the digitization of intraoperative assessments during cancer surgeries.
Ceros Financial Services Arranges $15 Million Financing For GT Metabolic Solutions
Ceros Financial Services will apply the raise to complete initial clinical trials for its incisionless Duodenal Ilial Bypass anastomosis for bariatric and metabolic surgery.